M Eric Gershwin
Overview
Explore the profile of M Eric Gershwin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
721
Citations
21525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang R, Lin Q, Sheng L, Zhang Y, Wen H, Li Y, et al.
J Autoimmun
. 2025 Feb;
152:103387.
PMID: 40015068
Background: Uncertainties persist regarding the optimal management of acute onset of autoimmune hepatitis, including the use of corticosteroids. This study aimed to compare the effectiveness and safety of rapid versus...
2.
Li Y, Leung P, Zhang W, Zhang S, Liu Z, Kurth M, et al.
J Autoimmun
. 2025 Feb;
151:103376.
PMID: 39892203
The biliary tract is now recognized as an immune organ, and within the biliary tract, both bile and cholangiocytes play a key role in maintaining immune defense and homeostasis. First,...
3.
Qin Z, Cheng F, Zhang M, Qian R, Chen H, Zhao Y, et al.
J Transl Autoimmun
. 2024 Dec;
9:100262.
PMID: 39654533
The detection of antimitochondrial antibodies (AMA) is the specific diagnostic marker for primary biliary cholangitis. Indeed, it is the most specific autoantibody in clinical autoimmunity, with a high titer directed...
4.
Yang B, Chen Y, Jiang J, Chang C, Wu H, Gershwin M, et al.
Clin Rheumatol
. 2024 Nov;
44(1):183-192.
PMID: 39579266
Objective: To evaluate the current usage of reproducible primary endpoints and tools for assessing treatment response for clinical trials for systemic lupus erythematosus (SLE), and emphasize the need for developing...
5.
Long J, Yang S, Bian Z, Zhu H, Ma M, Wang X, et al.
Adv Sci (Weinh)
. 2024 Nov;
12(1):e2407284.
PMID: 39494472
The specific mechanisms underlying effector pathways in autoimmune liver disease remain enigmatic and therefore constructing appropriate murine models to investigate disease pathogenesis becomes critical. A spontaneous severe murine model of...
6.
Rojas M, Acosta-Ampudia Y, Heuer L, Zang W, Monsalve D, Ramirez-Santana C, et al.
J Autoimmun
. 2024 Aug;
148:103303.
PMID: 39141985
Autoimmune diseases (ADs) showcase the intricate balance between the immune system's protective functions and its potential for self-inflicted damage. These disorders arise from the immune system's erroneous targeting of the...
7.
Zhang W, Al Tekreeti T, Leung P, Tsuneyama K, Dhillon H, Rojas M, et al.
Liver Int
. 2024 Aug;
44(10):2834-2846.
PMID: 39101371
Background And Aims: There is increased interest in utilizing dietary interventions to alter the progression of autoimmune diseases. These efforts are driven by associations of gut microbiota/metabolites with levels of...
8.
Qian Q, Wu Y, Cui N, Li Y, Zhou Y, Li Y, et al.
J Autoimmun
. 2024 Jul;
148:103289.
PMID: 39059058
Patients with primary biliary cholangitis (PBC) commonly experience extrahepatic rheumatic diseases. However, the epidemiologic and genetic associations as well as causal relationship between PBC and these extrahepatic conditions remain undetermined....
9.
Umemura M, Honda A, Yamashita M, Chida T, Noritake H, Yamamoto K, et al.
J Autoimmun
. 2024 Jul;
148:103287.
PMID: 39033687
Increasing evidence suggests that, in addition to a loss of tolerance, bile acid (BA) modulates the natural history of primary biliary cholangitis (PBC). We focused on the impacts of dietary...
10.
Wang R, Li B, Huang B, Li Y, Liu Q, Lyu Z, et al.
Gastroenterology
. 2024 May;
167(4):733-749.e3.
PMID: 38810839
Background & Aims: Gut dysbiosis and myeloid-derived suppressor cells (MDSCs) are implicated in primary biliary cholangitis (PBC) pathogenesis. However, it remains unknown whether gut microbiota or their metabolites can modulate...